Zonegran 25 mg
Zonegran 25 mg is a medicine authorised by Swissmedic under authorisation number 70551. The authorisation holder is EurimPharm Swiss AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 June 2026 and the authorisation is limited until 10 June 2031. ATC code N03AX15 places the medicine in the group Antiepileptics.
| Authorisation number | 70551 |
|---|---|
| Name | Zonegran 25 mg |
| Full name | Zonegran 25 mg, Kapseln |
| Authorisation holder | EurimPharm Swiss AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX15 |
| First authorisation | 11 June 2026 |
| Authorisation validity | 10 June 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zonegran 25 mg, Kapseln | B | 11 June 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Kapsel(n) | N03AX15 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zonegran 25 mg authorised in Switzerland?
Yes. Zonegran 25 mg is authorised by Swissmedic under authorisation number 70551, data as of 01 September 2026. The authorisation is limited until 10 June 2031.
Which dispensing category does Zonegran 25 mg have?
Zonegran 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Zonegran 25 mg?
The authorisation holder is EurimPharm Swiss AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.